Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Vivani Medical, Inc. (VANI : NSDQ)

• Company Description    Vivani Medical Inc. is the combination of Nano Precision Medical, Inc. and Second Sight Medical Products, Inc. The Company leverages proprietary technologies to develop and commercialize drug and device implants that treat patients with chronic diseases. Vivani Medical Inc., formerly known as Second Sight Medical Inc., is based in EMERYVILLE, Calif. Number of Employees: 36

• Price / Volume Information    Yesterday's Closing Price: $1.52 Daily Weekly Monthly 20 Day Moving Average: 538,279 shares Shares Outstanding: 63.25 (millions) Market Capitalization: $96.14 (millions) Beta: 3.15 52 Week High: $1.92 52 Week Low: $0.91 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 10.95% 8.04% 12 Week 21.60% 16.56% Year To Date 31.03% 14.54%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1350 S. LOOP ROAD - ALAMEDA,CA 94502 USA ph: 415-506-8462 fax: 818-833-5067 investors@vivani.com http://www.vivani.com

• General Corporate Information    Officers Adam Mendelsohn - Chief Executive Officer Gregg Williams - Chairman Brigid A. Makes - Chief Financial Officer Aaron Mendelsohn - Director Alexandra Larson - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 92854B109 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/12/25 Share - Related Items Shares Outstanding: 63.25 Most Recent Split Date: 8.00 (0.33:1) Beta: 3.15 Market Capitalization: $96.14 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.11 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.46 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/12/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 18.34 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -20.00% vs. Previous Quarter: -9.09% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 09/30/25 - - 06/30/25 - -194.66 03/31/25 - -133.07 ROA 09/30/25 - - 06/30/25 - -68.64 03/31/25 - -56.50 Current Ratio 09/30/25 - - 06/30/25 - 1.30 03/31/25 - 2.40 Quick Ratio 09/30/25 - - 06/30/25 - 1.30 03/31/25 - 2.40 Operating Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Net Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Pre-Tax Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Book Value 09/30/25 - - 06/30/25 - 0.08 03/31/25 - 0.20 Inventory Turnover 09/30/25 - - 06/30/25 - - 03/31/25 - - Debt-to-Equity 09/30/25 - - 06/30/25 - 0.00 03/31/25 - 0.00 Debt-to-Capital 09/30/25 - - 06/30/25 - 0.00 03/31/25 - 0.00

Powered by Zacks Investment Research ©